Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CAMMA', Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.204
EU - Europa 4.413
AS - Asia 1.871
AF - Africa 61
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 11
OC - Oceania 8
Totale 20.579
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.183
IT - Italia 1.490
CN - Cina 1.023
FI - Finlandia 856
SG - Singapore 614
UA - Ucraina 556
IE - Irlanda 343
DE - Germania 336
GB - Regno Unito 275
RU - Federazione Russa 138
SE - Svezia 125
RO - Romania 92
IN - India 60
FR - Francia 59
TR - Turchia 55
CI - Costa d'Avorio 54
KR - Corea 38
BE - Belgio 37
HK - Hong Kong 30
NL - Olanda 21
CA - Canada 20
CH - Svizzera 14
CZ - Repubblica Ceca 14
AT - Austria 11
IR - Iran 10
EU - Europa 9
ES - Italia 8
JP - Giappone 8
PL - Polonia 8
UZ - Uzbekistan 7
AU - Australia 6
GR - Grecia 6
LB - Libano 5
LT - Lituania 4
PK - Pakistan 4
TW - Taiwan 4
BG - Bulgaria 3
CL - Cile 3
DK - Danimarca 3
EG - Egitto 3
NG - Nigeria 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BR - Brasile 2
CO - Colombia 2
EC - Ecuador 2
IQ - Iraq 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AR - Argentina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
GE - Georgia 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
LV - Lettonia 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 20.579
Salva come PNG Salva come JPEG
Città #
Fairfield 2.562
Ashburn 1.277
Woodbridge 1.235
Chandler 1.099
Houston 955
Seattle 951
Wilmington 935
Cambridge 825
Ann Arbor 671
Singapore 509
Palermo 423
Dublin 343
Jacksonville 305
Medford 304
Altamura 226
Des Moines 218
Nanjing 198
Princeton 188
Lawrence 173
San Diego 128
New York 108
Boardman 97
Dearborn 91
Beijing 87
Santa Clara 87
Tulsa 85
Jinan 76
Shenyang 74
Nanchang 66
London 55
Abidjan 54
Hebei 53
Izmir 50
Jiaxing 47
Ludwigshafen am Rhein 47
Milan 46
Changsha 45
Tianjin 44
Saint Petersburg 38
Brussels 37
Ningbo 37
Zhengzhou 37
Kumar 32
Seongnam 30
Bremen 29
Los Angeles 28
Verona 28
Venice 27
Columbus 26
Guangzhou 26
Falls Church 25
San Paolo di Civitate 25
Hangzhou 24
Helsinki 23
Rome 22
Taizhou 20
Phoenix 19
Pune 19
Auburn Hills 18
Orange 17
Hong Kong 16
Lanzhou 16
Redwood City 16
Kilburn 15
Dallas 14
Düsseldorf 14
San Mateo 14
West Jordan 14
Munich 12
Haikou 11
Ottawa 11
Taiyuan 11
Washington 11
Chicago 10
Kunming 10
Central 9
Hefei 9
Edinburgh 8
Indiana 8
Moscow 8
Redmond 8
Tappahannock 8
Brno 7
Fuzhou 7
Hounslow 7
Napoli 7
Toronto 7
Aragona 6
Barcellona Pozzo di Gotto 6
Den Haag 6
Florence 6
Imola 6
Norwalk 6
Shanghai 6
Tehran 6
Acton 5
Afragola 5
Amsterdam 5
Atlanta 5
Chiswick 5
Totale 15.685
Salva come PNG Salva come JPEG
Nome #
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease 202
Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. 200
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis 199
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 191
Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C. 187
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. 186
PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease 177
Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response 176
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease 174
Inflammation and Aortic Stiffness: An Individual Participant Data Meta-Analysis in Patients With Inflammatory Bowel Disease. 172
Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C 170
Treatment of hepatocellular carcinoma: present and future. 169
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C 168
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. 167
High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis 158
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. 156
751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS 153
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease 153
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 152
The impact of radiotherapy on survival in resectable gastric carcinoma: A meta-analysis of literature data. 151
Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation 151
MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease 151
Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems 150
Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. 150
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women 148
Causes of and prevention strategies for hepatocellular carcinoma. 147
Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. 146
TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C 146
Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection 144
Clinical implications of the hyperdynamic syndrome in cirrhosis. 143
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 142
Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. 140
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension 140
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 140
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease 139
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study 138
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease 138
Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C 137
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. 137
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort 137
Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection. 135
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma. 135
Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing 133
Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C 132
Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis. 131
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 131
Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. 131
Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in post-operative Crohn's disease 130
High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C 130
Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients 130
Transjugular Intrahepatic Portosystemic Shunt For Refractory Ascites: A Meta-Analysis Of Individual Patient Data 129
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C 129
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 129
Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial 128
Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis 128
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. 128
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study 127
Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C 127
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values 127
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 127
Hyperferritinemia is a risk factor for steatosis in chronic liver disease. 127
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data 126
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity 126
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. results from a prospective study 126
THE COMPLEX INTERPLAY BETWEEN VITAMIN D DEFICIENCY AND DIABETES 125
Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy 125
Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data 125
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 125
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies 125
Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years 125
Reproductive status is associated with the severity of fibrosis in women with hepatitis C 124
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C 124
Assessment of treatment response in hepatocellular carcinoma: a review of literature 123
The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approach 122
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis 122
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease 122
When and how to treat acute hepatitis C? 122
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis 121
Treatment of hepatitis C: critical appraisal of the evidence 121
Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD 121
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy 120
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 120
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. 120
Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study 120
The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in inflammatory bowel diseases 120
Prevention of hepatocellular carcinoma 119
Treating patients with HCV genotype 1 and low viraemia: more than meets the eye 119
CT enterography as a powerful tool for the evaluation of inflammatory activity in Crohn's disease: relationship of CT findings with CDAI and acute-phase reactants 119
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease 119
Unsatisfactory quality of hepatological information on the internet 118
Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients 118
Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model 118
Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. 117
Insulin resistance is associated with steatosis in non-diabetic patients with genotype 1 chronic hepatitis C 117
Mortality in patients with hepatocellular carcinoma predicted by six scoring: none is the winner 116
Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C 116
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. 116
Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study 116
Genetic predisposition to thrombophilia in inflammatory bowel disease 114
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 114
Totale 13.755
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.537 0 0 0 0 0 729 646 456 675 315 545 171
2020/20213.065 184 258 185 297 261 164 192 237 342 395 259 291
2021/20222.423 178 522 62 68 66 98 137 142 297 249 189 415
2022/20233.136 338 663 44 352 306 484 176 211 382 17 110 53
2023/20241.197 52 205 67 88 89 300 115 59 22 31 28 141
2024/20251.175 76 186 296 348 114 155 0 0 0 0 0 0
Totale 21.485